Disruptive Pharma AB (publ) (STO:DPHA)
Sweden · Delayed Price · Currency is SEK 1.060
-0.076 (-6.69%)
At close: Oct 9, 2026
Disruptive Pharma AB Company Description
Disruptive Pharma AB (publ) operates as a pharmaceutical technology company in Sweden.
The company develops and commercializes Formulite, a patented and clinically evaluated platform technology for oral drug formulation and drug product development.
The company is based in Stockholm, Sweden.
Disruptive Pharma AB (publ)
| Country | Sweden |
| Founded | 2021 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Peter Åsberg |
Contact Details
Address: Box 5216 Stockholm, 102 45 Sweden | |
| Website | disruptivepharma.com |
Stock Details
| Ticker Symbol | DPHA |
| Exchange | Nasdaq Stockholm |
| Reporting Currency | SEK |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Peter Åsberg | Chief Executive Officer |
| Karin Botha | Chief Financial Officer |